TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis.
about
Matrix metalloproteinases in inflammatory bowel disease: an updateMonocyte Tumor Necrosis Factor-α-Converting Enzyme Catalytic Activity and Substrate Shedding in Sepsis and Noninfectious Systemic Inflammation.Ribosomal alteration-derived signals for cytokine induction in mucosal and systemic inflammation: noncanonical pathways by ribosomal inactivation.Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.Mapping orphan proteases by proteomics: meprin metalloproteases deciphered as potential therapeutic targets.Inflammatory Mediator Profiles Differ in Sepsis Patients With and Without Bacteremia.
P2860
TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@en
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@nl
type
label
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@en
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@nl
prefLabel
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@en
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@nl
P2860
P356
P1476
TNFα cleavage beyond TACE/ADAM ...... target in sepsis and colitis.
@en
P2093
Christoph Becker-Pauly
P2860
P304
P356
10.1002/EMMM.201302899
P577
2013-06-11T00:00:00Z